These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Regression of left ventricular hypertrophy in hypertensive patients after 1 year of treatment with rilmenidine: a double-blind, randomized, controlled (versus nifedipine) study. Sadowski Z, Szwed H, Kuch-Wocial A, Kubasik A, Januszewicz W, Krupa-Wojciechowska B, Polak G, Stejfa M, Dvorak I, Balazovjech I, Dubai G, Simon K. J Hypertens Suppl; 1998 Aug; 16(3):S55-62. PubMed ID: 9747912 [Abstract] [Full Text] [Related]
5. [Efficacy and tolerance of rilmenidine in patients with mild to moderate hypertension. Results of a Czech and Slovak 6-month multicenter study]. Widimský J. Vnitr Lek; 2002 Aug; 48(8):724-9. PubMed ID: 12425202 [Abstract] [Full Text] [Related]
7. Lipid profile and antihypertensive efficacy in hyperlipidemic hypertensive patients: comparison of rilmenidine and captopril. Scemama M, Février B, Beucler I, Dairou F. J Cardiovasc Pharmacol; 1995 Aug; 26 Suppl 2():S34-9. PubMed ID: 8642803 [Abstract] [Full Text] [Related]
20. Effect of Lactotripeptides (Isoleucine-Proline-Proline/Valine-Proline-Proline) on Blood Pressure and Arterial Stiffness Changes in Subjects with Suboptimal Blood Pressure Control and Metabolic Syndrome: A Double-Blind, Randomized, Crossover Clinical Trial. Cicero AF, Colletti A, Rosticci M, Cagnati M, Urso R, Giovannini M, Borghi C, D'Addato S. Metab Syndr Relat Disord; 2016 Apr; 14(3):161-6. PubMed ID: 26683986 [Abstract] [Full Text] [Related] Page: [Next] [New Search]